Sclerosis: all 3,103 studies
Page 23 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical CourseCompletedNCT02301572
- Step it Up: An Exercise and Behaviour Change Programme for People With Multiple SclerosisCompletedNCT02301442Not applicable
- Speed of Processing Training to Improve Cognition in Multiple SclerosisCompletedNCT02301260Not applicable
- Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)CompletedNCT02301247Not applicable
- Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study OutcomesCompletedNCT02297932Not applicable
- Robot-assisted Gait Training in Patients With Multiple Sclerosis: Efficacy and Comparison With Traditional MethodsStatus unknownNCT02291107Not applicable
- A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis LateralCompletedNCT02290886Phase 1/2
- Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis SubjectsCompletedNCT02287948
- Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple SclerosisCompletedNCT02287454Not applicable
- Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral SclerosisStatus unknownNCT02286011Phase 1
- Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 BCompletedNCT02283671Phase 1
- The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple SclerosisCompletedNCT02282878Not applicable
- A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCompletedNCT02282826Phase 1
- Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)CompletedNCT02280876Phase 1/2
- Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)WithdrawnNCT02278445Not applicable
- Disease Control in RRMS Transferring Treatment From Natalizumab to FingolimodCompletedNCT02277964
- Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple SclerosisCompletedNCT02275741
- Cognitive Motor Interference Rehabilitation in Persons With Multiple SclerosisCompletedNCT02274935Not applicable
- Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MSStatus unknownNCT02273635Phase 1/2
- A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALSTerminatedNCT02269436Phase 1
- Improving Cognitive Aptitudes With tDCS in Patients With Multiple SclerosisTerminatedNCT02266121Not applicable
- Exercise Intensity and Immune Function in Multiple SclerosisStatus unknownNCT02264704Not applicable
- Efficacy of Dalfampridine on Upper Extremity Function in Patients With MSStatus unknownNCT02259361Phase 4
- Robot-assisted Training of the Upper Limb in Persons With Multiple Sclerosis: an Randomized Controlled TrialCompletedNCT02257606Not applicable
- A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis PatientsCompletedNCT02253264Phase 1
- BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With BetaferonCompletedNCT02247310
- Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)TerminatedNCT02246348Not applicable
- Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by UltrasoundTerminatedNCT02243111Not applicable
- Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral SclerosisWithdrawnNCT02242071Phase 1
- Predicting Aortic Stenosis Progression by Measuring Serum Calcification PropensityCompletedNCT02241109Not applicable
- Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept StudyCompletedNCT02239393Phase 2
- PET Imaging in ALS PatientsCompletedNCT02236897Not applicable
- Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis?CompletedNCT02236624Not applicable
- Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon TherapyWithdrawnNCT02234869Phase 4
- Plegridy Observational ProgramCompletedNCT02230969
- Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT02228850Phase 2
- Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple SclerosisCompletedNCT02228213Phase 2
- Trekking Poles to Aid Multiple Sclerosis Gait ImpairmentCompletedNCT02227524Not applicable
- Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple SclerosisTerminatedNCT02222948Phase 2
- Effect of MD1003 in Spinal Progressive Multiple SclerosisStatus unknownNCT02220933Phase 3
- Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple SclerosisStatus unknownNCT02220244Phase 3
- Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MSTerminatedNCT02218879
- Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMSCompletedNCT02212886Phase 1/2
- Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic SclerosisCompletedNCT02212249Not applicable
- Balance and Falls in Multiple SclerosisCompletedNCT02209467Not applicable
- Measuring Active Microglia in Progressive Multiple SclerosisCompletedNCT02207075
- EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSISStatus unknownNCT02206672Not applicable
- Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADACompletedNCT02205489Phase 4
- A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple SclerosisStatus unknownNCT02200718Phase 1
- Mobility Enhancing Nursing InterventionCompletedNCT02198599Not applicable
- Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation ProgramStatus unknownNCT02193906Not applicable
- Biological Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT02193893Phase 1
- Tamoxifen Treatment in Patients With Motor Neuron DiseaseCompletedNCT02166944Phase 1/2
- Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple SclerosisCompletedNCT02166021Phase 2
- Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)CompletedNCT02159573
- Outcomes Data of Adipose Stem Cells to Treat Multiple SclerosisStatus unknownNCT02157064
- A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple SclerosisStatus unknownNCT02149706Phase 2
- Resistance Training and Amino Pyridine in Multiple SclerosisCompletedNCT02143167Phase 4
- Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis PatientsCompletedNCT02142764Not applicable
- Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT02142205Phase 4
- Natalizumab Subcutaneous Immunogenicity and Safety StudyTerminatedNCT02142192Phase 2
- Computerized Cognitive Exercise Training Treatment for Adults With Multiple SclerosisStatus unknownNCT02141386Not applicable
- Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With GilenyaCompletedNCT02141022Not applicable
- Sphingosine-1 Phosphate -Receptor Targeting and Microglial ActivationCompletedNCT02139696
- Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With GilenyaCompletedNCT02137707
- Safety and Efficacy in Pediatric MS Patients Prescribed TysabriCompletedNCT02137109
- Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness StudyCompletedNCT02137044Not applicable
- Mindfulness-based Stress Reduction in Multiple SclerosisCompletedNCT02136485Not applicable
- Stabilometric Assessment of Balance Recovery in Persons With Multiple SclerosisCompletedNCT02131285Not applicable
- Treating Foot Drop in People With Multiple Sclerosis Using Electrical StimulationCompletedNCT02123537Not applicable
- Allocentric Memory in MS and Resting State Functional MRICompletedNCT02118298
- Mesenchymal Stem Cell Injection in Amyotrophic Lateral SclerosisWithdrawnNCT02116634Phase 1/2
- Study of Exercise on Impact of Cognitive Functioning in Multiple Sclerosis PatientsStatus unknownNCT02106052Not applicable
- Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic SclerosisCompletedNCT02105818
- Protective Role of Oxcarbazepine in Multiple SclerosisCompletedNCT02104661Phase 2
- Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple SclerosisStatus unknownNCT02104492Not applicable
- Implementing Physical Activity Guidelines for Adults With MSCompletedNCT02100020Not applicable
- Adherence to Treatment With Tecfidera™ in Multiple Sclerosis PatientsCompletedNCT02099370
- Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis ComplexStatus unknownNCT02098759Not applicable
- Vitamin D3 and the Stress-axis in MSTerminatedNCT02096133Phase 2
- Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl FumarateWithdrawnNCT02090348Phase 4
- Safety and Tolerability of Quetiapine in Multiple SclerosisCompletedNCT02087631Phase 1/2
- Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - TicinoCompletedNCT02082002
- Consolidation & Interference in Multiple SclerosisCompletedNCT02081508Not applicable
- Tolerability and Quality of Life Study in Participants Who Switched to Avonex PenCompletedNCT02076841
- Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple SclerosisCompletedNCT02065284Not applicable
- Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple SclerosisStatus unknownNCT02059096Phase 3
- Therapeutic Imaging Biomarkers for Amyotrophic Lateral SclerosisTerminatedNCT02058732Not applicable
- A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple SclerosisStatus unknownNCT02057159Phase 2/3
- Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) PatientsTerminatedNCT02048358Phase 1
- Upper Limbs Intervention in Multiple SclerosisCompletedNCT02047825Not applicable
- Dimethyl Fumarate (DMF) Observational StudyCompletedNCT02047097
- Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis CriterionCompletedNCT02043964Not applicable
- Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple SclerosisCompletedNCT02035514Phase 1/2
- Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple SclerosisCompletedNCT02034188Phase 1/2
- Impact of CRISP on Self-Efficacy, Loneliness, and DepressionCompletedNCT02030197Not applicable
- Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT02021162
- Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 MonthsCompletedNCT02017808
- Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic PainCompletedNCT02012439Phase 1/2
- Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple SclerosisWithdrawnNCT02011451Phase 2